SecBot SecBot
425 ·Filed Sep 14, 2026

MDT

Medtronic plc
NEUTRAL
Impact 5/10
Horizonweeks Processed2mo ago SEC0001628280-26-061674
Rule 425 M&A communications
Actionable Insight • Neutral

The exchange offer provides a tax-efficient path for MDT shareholders to gain direct exposure to MiniMed at a discount. Monitor the final exchange ratio announcement (expected Oct 8) and subscription level, oversubscription would fully separate MiniMed, while undersubscription triggers alternative divestiture. The 7% discount may attract arbitrage activity, but the offer is voluntary and no action is needed for non-participants.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$93.80
T+0 close · Sep 14, 2026 · via day close
Latest settled
−1.99%
T+20 · $91.93 · next T+60 in 21d
Vs SPY
−4.26%
α at T+20
Latest observation
+11.51%
T+44 · FF3 residual α
  1. T+0 · Sep 14 $93.80entry
  2. T+1 · 2mo ago −0.05%α +0.41% · $93.75
  3. T+5 · 8w ago −2.19%α −2.29% · $91.75
  4. T+20 · 5w ago −1.99%α −4.26% · $91.93
  5. T+45 · todayOpen
  6. T+60 · in 21d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medtronic launched an exchange offer to split off at least 80.1% of MiniMed Group (its former Diabetes business) to MDT shareholders. Shareholders can exchange MDT shares for MMED shares at a 7% discount (~$107.53 of MMED stock per $100 of MDT stock tendered), with the offer expiring October 9, 2026. This completes the separation of MiniMed following its March 2026 IPO, allowing Medtronic to refocus capital on Cardiovascular, Neuroscience, and Surgical portfolios.

Key Facts

  • Medtronic launched an exchange offer to split off at least 80.1% of MiniMed Group (Nasdaq: MMED) to MDT shareholders.
  • Shareholders can exchange MDT ordinary shares for MMED common stock at a 7% discount, subject to an upper limit of 4.5939 MMED shares per MDT share.
  • If the upper limit is not in effect, tendering shareholders are expected to receive ~$107.53 of MMED stock for every $100 of MDT stock tendered.
  • Medtronic currently owns ~90% of MiniMed (252,813,348 shares) and is offering up to 225,361,295 MMED shares in the exchange.
  • If oversubscribed, Medtronic intends to exchange all remaining 27,452,053 MMED shares; if undersubscribed, it will divest remaining shares via spin-off, split-off, or debt-for-equity exchange.
  • Conditions include at least 112,680,647 MMED shares being issued and a tax-free opinion from counsel.
  • The exchange offer expires October 9, 2026, with the final exchange ratio announced by October 8, 2026.
  • Goldman Sachs and BofA Securities are dealer managers.

Financial Impact

Exchange offer at ~7% discount to MDT; ~$107.53 of MMED per $100 of MDT tendered. Medtronic owns ~90% of MiniMed (252.8M shares).

share countownership structurecapital allocation

Risk Factors

  • Exchange offer may not meet minimum subscription condition (112.68M MMED shares)
  • Tax-free treatment depends on receipt of favorable opinion of counsel
  • Undersubscription could lead to alternative divestiture methods with uncertain terms
  • MiniMed's performance as an independent company carries execution risk

Market Snapshot

Exchange
NYSE
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
68% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001628280-26-061674
Document: 0001628280-26-061674-index-headers.html0001628280-26-061674
Document: 0001628280-26-061674-index.html0001628280-26-061674
Document: 0001628280-26-061674.txt0001628280-26-061674

Track record

53 reports on MDT

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.30% at T+60 after the Jun 3, 2026 report. 9 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $101.59 Now $102.88 +1.27% settles Feb 8
  3. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $98.88 Now $102.88 +4.05% settles Feb 1
  4. Oct 19, 202628d ago 8-K Neutral 4/10 Entry $94.63 Now $102.88 +8.72% settles Jan 15
  5. Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
  6. Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
  7. Oct 15, 20264w ago 144 Neutral 3/10 Entry $95.45 Now $102.88 +7.78% settles Jan 12
  8. Oct 14, 20264w ago SC TO-I/A Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
  9. Oct 14, 20264w ago 425 Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
  10. Oct 13, 20264w ago SC TO-I/A Neutral 5/10 Entry $93.01 Now $102.88 +10.61% settles Jan 8
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (11h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026